Participating in the SWEET Study may help you lower blood sugar levels following a pregnancy with gestational diabetes
Did you know research has shown the risk for getting type 2 diabetes is nearly 10 times higher for women who have had gestational diabetes during pregnancy compared to women who have not?
Researchers at Woman’s Hospital are launching the SWEET Study to learn if a once-a-week medicine, called semaglutide, can help women get rid of prediabetes and have healthy blood sugar levels after a pregnancy with gestational diabetes. The study lasts for 9 months and will compensate participants up to $800.
More about semaglutide (Ozempic®): Studies have already shown that the FDA approved drug semaglutide (Ozempic®) can help treat type 2 diabetes. For women who have recently given birth following a diagnosis of gestational diabetes, Ozempic® may be able to improve blood sugar levels, treat pre-diabetes, help with weight loss, and get you back to living your best life.
Do I qualify to join the SWEET Study?
- You must be less than 3 years postpartum (no more than 36 months after having your baby)
- Not pregnant or breastfeeding right now
- Had gestational diabetes in your most recent pregnancy
- Be between 18 and 45 years old
What does the study involve?
The study will last about 9 months, will be require 7 visits, and involves:
- Blood draws, urine collections, and lab tests to measure your general health, diabetes status (how your body handles sugar), and pregnancy status (see if you are pregnant or not).
- Measurement of your body weight, height, blood pressure, and a body composition scan (called a DEXA) to measure how much body fat you have.
- Wearing a small device to measure your blood sugar levels for 10 days
- Record the food you have been eating for 24 hours
Why should I participate?
If you are eligible, you will receive detailed labs and insight into your current health status. While the medicine used in this study has been used to improve blood sugar levels in adults with type 2 diabetes, it is not guaranteed to have similar effects in women with pre-diabetes. You would also get up to $800 for taking part in the study.